A Phase II trial of S-1 and concurrent radiotherapy for locally advanced pancreatic cancer.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 14 Sep 2009 Planned end date (Jan 2010) added as reported as reported by University Hospital Medical Information Network - Japan.
- 14 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
- 30 Oct 2006 New trial record.